Pharmaxis to acquire Canadian company TOPIGEN Pharmaceuticals Inc.

12th Jan 10

Release Date: 12/01/2010 12:00am

Pharmaxis Ltd (ASX:PXS) announced today that it has signed an agreement to acquire Canadian based private biopharmaceutical company Topigen Pharmaceuticals Inc. in a transaction that will enhance the Pharmaxis respiratory drug development portfolio and complement the existing products and drugs under development.


Read full media release - pdf

Categories: News and Media